Antimicrobial susceptibility of Staphylococcus spp. goat mastitis isolatesin semi-intensive and extensive production systems
Introduction: Goat milk production has experienced sustained growth in recent years. Subclinical mastitis, a disease caused mainly by Staphylococcus spp., has a high economic and health impact at a global level. However, there is little information on the antimicrobial susceptibility of these pathogens, a fundamental aspect of successful therapy. The objectives of this study were to determine the occurrence of subclinical mastitis due to Staphylococcus spp. in semi-intensive and extensive systems and to evaluate the antibacterial susceptibility in S. aureus and scn isolated from milk of goats with subclinical mastitis.
Methodology: We worked with 200 goats in the extensive system and 104 in the semi-intensive system. Using the California Mastitis Test, 55 and 95 goats suspected of subclinical mastitis were selected from both systems, respectively. Milk samples were obtained and cultured in CHROMagar™ Staph aureus®. S. aureus and scn were identified by color, metabolic, and biochemical tests. Antimicrobial susceptibility was evaluated by the agar diffusion method.
Results: scn were the main microorganisms isolated in both systems, presenting greater resistance to penicillin, erythromycin, and gentamicin. There was only multiple resistance phenotype in the semi-intensive system. S. aureus presented multiple phenotypes in both systems. The percentages of antimicrobial resistance found in the extensive system were significantly higher than in the semi-intensive system (p = 0.0016).
Conclusions: These findings reflect the importance of implementing prudent use of antimicrobials under professional supervision, as occurs in semi-intensive treatments, and the need to monitor antimicrobial susceptibility in a sustained manner.
Copyright (c) 2025 Spei Domus
This work is licensed under a Creative Commons Attribution 4.0 International License.
En calidad de autor del artículo, declaro que este, es un trabajo original, inédito, de mi creación exclusiva, que no se ha postulado a evaluación simultánea en otra publicación y que no cuenta con algún impedimento de cualquier naturaleza para la concesión de los derechos previstos en este contrato.
En ese sentido, me comprometo a esperar un resultado de evaluación de la revista, antes de considerar su presentación a otro medio, en caso de que la respuesta de publicación no sea positiva; adicionalmente, me comprometo a responder por cualquier acción de reivindicación, plagio u otra clase de reclamación que al respecto pudiera sobrevivir por parte de terceros.
Asimismo, declaro que como autor o coautor, estoy de acuerdo por completo con los contenidos presentados en este trabajo y cedo todos los derechos patrimoniales, es decir, la reproducción, comunicación pública, distribución, divulgación, transformación, puesta a disposición y demás formas de explotación de la obra por cualquier medio o procedimiento, a la revista y a la Editorial de la Universidad Cooperativa de Colombia.
